Clinical Trials · NCT03842202
A Research Study to Look at How Semaglutide Affects Gastric Emptying in People With Obesity
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 72
- Start date
- Feb 2019
- Locations
- 1 site, Germany
- Primary endpoint
- AUC0-5h,para: the area under the paracetamol concentration-time curve from 0 to 5 hours at steady state